|
WBF-038 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Akkermansia muciniphila/Anaerobutyricum hallii/Bifidobacterium infantis/Clostridium beijerinckii/Clostridium butyricum/Inulin WBF-038, Pendulum WBF-038 (SY), Probiotic/Prebiotic Formulation WBF-038 (SY), Synbiotic Formulation WBF-038 (SY), WBF 038 (CN), WBF-038 (CN), WBF038 (CN)
Jacksonville, Florida1 trial
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Mayo Clinic in Florida
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.